Ayala Pharmaceuticals Inc (ADXS)

[Batermere]

raja.... good question. Evidently, based on the clinical results that we DO have from GOG, head and neck cancer and anal cancer (even though the sample sizes were quite low) .... the Reward VS the Risk is not quite there yet according to potential BP suitors. I find that baffling in today's Biotech landscape when BPs are paying a lot of money for small Baby Biotechs that have NO products as far along as what ADXS has currently. It's a real head scratcher, I must admit. Maybe it will take EU Approval to get there. Unfortunately, that is probably going to be at least a year away as slow as ADXS is. They just continue to hobble along at a snail's pace with ZERO sense of urgency. It's very frustrating.